Atlas Venture

I need to feel always a little bit, I don't know what's going on and I need to learn and I need to apply myself.

And so decided to leave Novartis and join early company formation at Atlas Venture.

And then there I met Bruce Booth, with whom we decided in late 2015 to build a protein degradation company.

So from there, obviously Chimera's story started, and obviously it's been 10 years in the making, still a long way to go.

Thanks, Dello.

We'll talk about some of the work that you did at Nibiru, particularly with working on a first-in-class FDA-approved factor B inhibitor.

But I wanted to go back to the founding days of Chimera, and you were at Atlas Ventures, an entrepreneur in residence.

Talk to us about that process and the exercise of creating a company 10-plus years ago and what that experience was like for you.